These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33390935)

  • 1. Fluorofenidone Alleviates Renal Fibrosis by Inhibiting Necroptosis Through RIPK3/MLKL Pathway.
    Dai Q; Zhang Y; Liao X; Jiang Y; Lv X; Yuan X; Meng J; Xie Y; Peng Z; Yuan Q; Tao L; Huang L
    Front Pharmacol; 2020; 11():534775. PubMed ID: 33390935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Necroptosis Attenuates Kidney Inflammation and Interstitial Fibrosis Induced By Unilateral Ureteral Obstruction.
    Xiao X; Du C; Yan Z; Shi Y; Duan H; Ren Y
    Am J Nephrol; 2017; 46(2):131-138. PubMed ID: 28723681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis.
    Yang H; Zhang W; Xie T; Wang X; Ning W
    Braz J Med Biol Res; 2019; 52(11):e8772. PubMed ID: 31664306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
    Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
    Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis.
    Qin J; Xie YY; Huang L; Yuan QJ; Mei WJ; Yuan XN; Hu GY; Cheng GJ; Tao LJ; Peng ZZ
    Nephrology (Carlton); 2013 Oct; 18(10):690-9. PubMed ID: 23841831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorofenidone attenuates renal fibrosis by inhibiting the mtROS-NLRP3 pathway in a murine model of folic acid nephropathy.
    Liao X; Jiang Y; Dai Q; Yu Y; Zhang Y; Hu G; Meng J; Xie Y; Peng Z; Tao L
    Biochem Biophys Res Commun; 2021 Jan; 534():694-701. PubMed ID: 33220928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF-κB pathway.
    Tu S; Jiang Y; Cheng H; Yuan X; He Y; Peng Y; Peng X; Peng Z; Tao L; Yang H
    FASEB J; 2021 Jul; 35(7):e21497. PubMed ID: 34152015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II triggers RIPK3-MLKL-mediated necroptosis by activating the Fas/FasL signaling pathway in renal tubular cells.
    Zhu Y; Cui H; Lv J; Li G; Li X; Ye F; Zhong L
    PLoS One; 2020; 15(3):e0228385. PubMed ID: 32134954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage.
    Liao X; Lv X; Zhang Y; Han Y; Li J; Zeng J; Tang D; Meng J; Yuan X; Peng Z; Tao L; Xie Y
    Oxid Med Cell Longev; 2022; 2022():2453617. PubMed ID: 35355864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
    Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
    Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorofenidone attenuates oxidative stress and renal fibrosis in obstructive nephropathy via blocking NOX2 (gp91phox) expression and inhibiting ERK/MAPK signaling pathway.
    Qin J; Mei WJ; Xie YY; Huang L; Yuan QJ; Hu GY; Tao LJ; Peng ZZ
    Kidney Blood Press Res; 2015; 40(1):89-99. PubMed ID: 26029782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorofenidone attenuates inflammation by inhibiting the NF-кB pathway.
    Huang L; Zhang F; Tang Y; Qin J; Peng Y; Wu L; Wang F; Yuan Q; Peng Z; Liu J; Meng J; Tao L
    Am J Med Sci; 2014 Jul; 348(1):75-80. PubMed ID: 24534785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice.
    Wang H; Zhang J; Zhang X; Zhao N; Zhou Z; Tao L; Fu L; Peng S; Chai J
    Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166556. PubMed ID: 36154893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorofenidone Attenuates Renal Interstitial Fibrosis by Enhancing Autophagy and Retaining Mitochondrial Function.
    Liu W; Zhou H; Dong H; Xing D; Lu M
    Cell Biochem Biophys; 2023 Dec; 81(4):777-785. PubMed ID: 37735328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necroptosis occurs in osteoblasts during tumor necrosis factor-α stimulation and caspase-8 inhibition.
    Shi G; Jia P; Chen H; Bao L; Feng F; Tang H
    Braz J Med Biol Res; 2018 Nov; 52(1):e7844. PubMed ID: 30484493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calycosin pretreatment enhanced the therapeutic efficacy of mesenchymal stem cells to alleviate unilateral ureteral obstruction-induced renal fibrosis by inhibiting necroptosis.
    Hu Q; Zhu B; Yang G; Jia J; Wang H; Tan R; Zhang Q; Wang L; Kantawong F
    J Pharmacol Sci; 2023 Feb; 151(2):72-83. PubMed ID: 36707181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-Bound Polysaccharides from
    Pawlikowska M; Jędrzejewski T; Brożyna AA; Wrotek S
    Cell Physiol Biochem; 2020 Jun; 54(4):591-604. PubMed ID: 32531147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxiredoxin 1 inhibits the oxidative stress induced apoptosis in renal tubulointerstitial fibrosis.
    Mei W; Peng Z; Lu M; Liu C; Deng Z; Xiao Y; Liu J; He Y; Yuan Q; Yuan X; Tang D; Yang H; Tao L
    Nephrology (Carlton); 2015 Nov; 20(11):832-42. PubMed ID: 25989822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal obstructive nephropathy induces necroptosis and necroinflammation.
    Popper B; Rammer MT; Gasparitsch M; Singer T; Keller U; Döring Y; Lange-Sperandio B
    Sci Rep; 2019 Dec; 9(1):18600. PubMed ID: 31819111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Protective Effect of Fluorofenidone against Cyclosporine A-Induced Nephrotoxicity.
    Chen Y; Wang N; Yuan Q; Qin J; Hu G; Li Q; Tao L; Xie Y; Peng Z
    Kidney Blood Press Res; 2019; 44(4):656-668. PubMed ID: 31387101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.